Design of oncology clinical trials: A review

被引：14
|
作者：
Ananthakrishnan, Revathi
Menon, Sandeep
机构：
[1] #3 Cambridge, MA 02138
[2] #1 Newton, MA 02460, One Townhouse Drive
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2013年 / 88卷 / 01期
关键词：
Phases I; II and III oncology clinical trials; Trial designs; Safety and efficacy endpoints; PK/PD modeling; Statistical analyses; CONTINUAL REASSESSMENT METHOD; RESPONSE EVALUATION CRITERIA; ANTIBODY-DRUG CONJUGATE; TOXICITY TRADE-OFFS; PRACTICAL CONSIDERATIONS; TRASTUZUMAB EMTANSINE; HYPOTHESES SELECTION; INTERIM ANALYSES; DOSE-ESCALATION; 2-STAGE DESIGNS;
D O I：
10.1016/j.critrevonc.2013.03.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cancer is a disease that occurs due to the uncontrolled multiplication of cells that invade nearby tissues and can spread to other parts of the body. An increased incidence of cancer in the world has led to an increase in oncology research and in the number of oncology trials. Well designed oncology clinical trials are a key part of developing effective anti-cancer drugs. This-review focuses on statistical considerations in the design and analysis of oncology clinical trials. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：144 / 153
页数：10
相关论文
共 50 条
  • [21] The design, analysis and application of mouse clinical trials in oncology drug development
    Sheng Guo
    Xiaoqian Jiang
    Binchen Mao
    Qi-Xiang Li
    BMC Cancer, 19
  • [22] Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology
    Cabarrou, Bastien
    Sfumato, Patrick
    Mourey, Loic
    Leconte, Eve
    Balardy, Laurent
    Martinez, Alejandra
    Delord, Jean-Pierre
    Boher, Jean-Marie
    Brain, Etienne
    Filleron, Thomas
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : 120 - 126
  • [23] Endpoints in oncology clinical trials
    Kilickap, Saadettin
    Demirci, Umut
    Karadurmus, Nuri
    Dogan, Mutlu
    Akinci, Bulent
    Sendur, Mehmet Ali Nahit
    JOURNAL OF BUON, 2018, 23 : S1 - S6
  • [24] Crossover in oncology clinical trials
    Diaz, Jose
    Sternberg, Cora N.
    Mehmud, Faisal
    Delea, Thomas E.
    Latimer, Nicholas
    Bartlett-Pandite, Arundathy N.
    Motzer, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Clinical trials of interventional oncology
    Arai, Yasuaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (04) : 301 - 305
  • [26] Clinical trials in neurosurgical oncology
    Murphy, Meghan
    Parney, Ian F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (03) : 569 - 576
  • [27] Clinical Trials in Precision Oncology
    Mockus, Susan M.
    Patterson, Sara E.
    Statz, Cara
    Bult, Carol J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY, 2016, 62 (03) : 442 - 448
  • [28] Endpoints of clinical trials in oncology
    Roila, F
    Del Favero, A
    Ballatori, E
    TUMORI JOURNAL, 1997, 83 (06): : S8 - S13
  • [29] Adaptive clinical trials in oncology
    Berry, Donald A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (04) : 199 - 207
  • [30] Clinical trials in neurosurgical oncology
    Meghan Murphy
    Ian F. Parney
    Journal of Neuro-Oncology, 2014, 119 : 569 - 576
12345